Clinical Trial Update: The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

View source ↗

Summary

The clinical trial update assesses the prognostic value of PET/CT imaging for tumor progression in patients with metastatic hormone-sensitive prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Prostate Cancer Metastatic Disease, PET / CT | Status: COMPLETED